Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -57.073\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCN1CCN(C(=O)/C(=C/c2ccco2)NC(=O)c2ccccc2)CC1
b) CC(=O)N1CCN(c2ccc(Nc3ncnc4c3oc3ccccc34)cc2)CC1.Cl
c) Cc1ccc(N=Cc2c(O)[nH]c3ccccc23)c([N+](=O)[O-])c1
Answer: a. CCN1CCN(C(=O)/C(=C/c2ccco2)NC(=O)c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1CCN(C(=O)/C(=C/c2ccco2)NC(=O)c2ccccc2)CC1
CCN1CCN(C(=O)/C(=C/c2ccco2)NC(=O)c2ccccc2)CC1
N-[(Z)-3-(4-ethylpiperazin-1-yl)-1-(furan-2-yl)-3-oxoprop-1-en-2-yl]benzamide